• 1. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 2. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 5. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324

4-(Chloromethyl)-1-isopropyl-1H-pyrazole hydrochloride: A Comprehensive Overview

4-(Chloromethyl)-1-isopropyl-1H-pyrazole hydrochloride (CAS No. 1401425-39-5) is a significant compound in the field of pharmaceutical chemistry, known for its versatile applications in drug discovery and development. This article provides an in-depth exploration of the compound, its chemical properties, synthesis methods, and recent advancements in its utilization within the pharmaceutical industry.

The molecular structure of 4-(Chloromethyl)-1-isopropyl-1H-pyrazole hydrochloride consists of a pyrazole core substituted with a chloromethyl group at the 4-position and an isopropyl group at the 1-position, with the hydrochloride salt form enhancing its solubility and stability. This unique arrangement imparts distinct reactivity, making it a valuable intermediate in organic synthesis and medicinal chemistry.

In recent years, 4-(Chloromethyl)-1-isopropyl-1H-pyrazole hydrochloride has garnered attention for its role in the development of novel therapeutic agents. Its chloromethyl functionality allows for facile introduction of various pharmacophores, facilitating the creation of bioactive molecules. Researchers have leveraged this compound to design inhibitors targeting specific enzymatic pathways involved in diseases such as cancer, inflammation, and infectious disorders.

One of the most compelling applications of 4-(Chloromethyl)-1-isopropyl-1H-pyrazole hydrochloride is in the synthesis of kinase inhibitors. Kinases are critical enzymes that regulate numerous cellular processes, and their dysregulation is often associated with pathological conditions. By incorporating the pyrazole scaffold into kinase inhibitors, scientists have been able to develop more potent and selective drugs. For instance, derivatives of this compound have shown promise in preclinical studies as inhibitors of Janus kinases (JAKs), which play a pivotal role in immune responses and hematopoiesis.

The synthesis of 4-(Chloromethyl)-1-isopropyl-1H-pyrazole hydrochloride involves multi-step organic reactions, typically starting from commercially available pyrazole derivatives. The chloromethylation step is a key transformation that introduces the chloromethyl group at the 4-position. This reaction is often carried out under controlled conditions to ensure high yield and purity. The subsequent formation of the hydrochloride salt enhances the compound's stability and bioavailability, making it more suitable for pharmaceutical applications.

Recent studies have highlighted the potential of 4-(Chloromethyl)-1-isopropyl-1H-pyrazole hydrochloride in developing antiviral agents. The pyrazole moiety is known to exhibit broad-spectrum antiviral activity by interfering with viral replication mechanisms. Researchers have synthesized various derivatives of this compound and evaluated their efficacy against different viruses. Notably, some derivatives have demonstrated inhibitory effects on RNA viruses, including those responsible for influenza and hepatitis C.

The pharmacokinetic properties of 4-(Chloromethyl)-1-isopropyl-1H-pyrazole hydrochloride are also subjects of ongoing research. Understanding how the compound is absorbed, distributed, metabolized, and excreted (ADME) is crucial for optimizing its therapeutic potential. Preliminary studies suggest that this compound exhibits moderate solubility in water and lipids, which may influence its bioavailability and tissue distribution. Further investigations are needed to fully elucidate these properties and to identify potential drug-drug interactions.

In conclusion, 4-(Chloromethyl)-1-isopropyl-1H-pyrazole hydrochloride (CAS No. 1401425-39-5) is a versatile compound with significant implications in pharmaceutical research and development. Its unique chemical structure and reactivity make it a valuable tool for synthesizing novel therapeutic agents targeting various diseases. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in the discovery and development of next-generation drugs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)